Common questions about Бруфен СР (FAQ)
Q: What is the difference between Бруфен СР and regular Бруфен?
The core difference is the way the medicine is released into the body. The 'СР' designation stands for sustained-release, meaning it is designed to work over a prolonged period.
This design supports a prolonged therapeutic effect, which is generally associated with needing fewer doses each day compared to regular (immediate-release) ibuprofen.
Q: What kind of pain is Бруфен СР typically used for?
According to official product information, the medicine is indicated for the relief of mild to moderate pain. This includes common issues like headache, dental pain, backache, rheumatic or muscular pain, and dysmenorrhoea (period pain).
It is also utilized for its ability to reduce fever.
Q: Is Бруфен СР used for migraines or just tension headaches?
The active ingredient, Ibuprofen, is listed in official documentation as being used for the relief of general headache pain and migraine pain.
Q: Can Бруфен СР cause drowsiness or affect alertness?
Regulatory data lists undesirable effects such as dizziness, headache, and somnolence (drowsiness). Official warnings state that if these effects occur, activities requiring mental alertness, such as driving or operating machinery, may be impaired.
Q: Is Бруфен СР described as safe for use during pregnancy?
Use of this medicine is strictly contraindicated (must not be used) during the third trimester of pregnancy, typically starting from 20 weeks onward, due to potential risks to the fetus. Use during the first and second trimesters requires careful consideration by a healthcare professional.
Q: Does regulatory information mention any known risks for the kidneys with long-term use?
Yes, official regulatory documents state that long-term use of NSAIDs like this one can be associated with renal (kidney) changes, such as renal papillary necrosis. For long-term users, regulatory information specifies that medical supervision and regular monitoring of renal function should occur.
Q: What kind of allergic reactions are listed in the safety data?
The documented range of allergic reactions spans from uncommon effects like rhinitis (runny nose) and hives (urticaria) to rare, severe reactions. These severe reactions include anaphylaxis and severe skin conditions like Stevens-Johnson Syndrome (SJS).
Q: How does the sustained release work differently from an immediate release tablet?
The sustained-release tablet is a modified formulation designed to control the rate at which the medicine is absorbed, allowing it to maintain therapeutic levels for a longer duration compared to immediate-release tablets.
This design supports a prolonged therapeutic effect, which is generally associated with needing fewer doses each day.
Q: Are there different strengths of Бруфен СР available?
The official product information detailing the administration schedule refers to 800 mg tablets. The availability of any other specific sustained-release strengths for this product would be detailed in the official package information.
Q: Are changes in blood pressure or heart rhythm mentioned as potential side effects?
Hypertension (high blood pressure) is listed as a very rare potential undesirable effect in regulatory data. Furthermore, serious cardiovascular events associated with NSAID use may present with signs such as a fast or irregular heartbeat.
Q: How quickly does Бруфен СР usually start to work?
As a sustained-release formulation, the medicine is designed for a prolonged effect rather than a rapid peak in concentration. Official information indicates that the onset of action may be delayed if the tablet is taken shortly after eating a meal.
Q: How long are the effects of Бруфен СР expected to last?
The sustained-release design ensures the active ingredient is released over an extended period. This mechanism is intended to provide prolonged symptom management, which supports the product's typical dosing schedule of only once or twice a day.
Q: Is there a warning about driving or operating machinery while using Бруфен СР?
Yes, official product information contains warnings regarding caution. If side effects such as dizziness, headache, or drowsiness occur, activities requiring mental alertness, such as driving or operating machinery, may be impaired and should be avoided.
Q: Are there any specific foods to avoid when taking Бруфен СР?
Regulatory information does not list any specific foods that are prohibited while using this medicine. However, official guidance states that taking the tablet shortly after a meal may cause the onset of the medicine's action to be delayed.
Q: Is Бруфен СР suitable for people with asthma?
The medicine is considered inappropriate (contraindicated) for individuals who have previously had an allergic reaction, such as asthma or bronchospasm, after taking Aspirin or any other NSAID. Caution is specifically required for patients who have a known history of bronchial asthma.
Q: What does official guidance say about using Бруфен СР while breastfeeding?
Official guidance indicates that the active ingredient, Ibuprofen, is known to pass into breast milk in very small amounts. It is often cited as a preferred pain reliever for nursing mothers. Consultation with a healthcare professional is necessary prior to use.
Q: Is the effect of Бруфен СР reduced if taken with food?
Regulatory information notes that taking the medicine shortly after a meal may delay the initial onset of its action. However, official documents do not state that the overall therapeutic effect or the full benefit of the sustained release is reduced by consuming food.
Q: What should a patient do if they miss a scheduled time to take the medicine?
Official patient information states that a dose should not be doubled to compensate for a forgotten one. If a dose is missed, patients should revert to the normal schedule and take their next dose at the usual time.
Q: Are there any warnings about sun exposure while taking this drug?
Photosensitivity reactions (increased sensitivity to sunlight) are documented as an uncommon side effect in regulatory documents. Protective measures against sun exposure are generally advised.
Q: Is there information on how the drug is eliminated from the body?
Official pharmacological information states that the active ingredient is metabolized (broken down) primarily in the liver. The resulting metabolites are then mainly excreted from the body via the urine.
Q: What are the signs of taking too much Бруфен СР?
Regulatory documents list several symptoms associated with overdose, which can include dizziness, headache, vomiting, nausea, and abdominal pain. More serious signs may involve confusion, a decreased level of consciousness, and seizures. If overdose is suspected, immediate medical assistance is necessary.
Q: Does the regulatory body recommend any specific monitoring while on this medicine?
Yes, official documentation advises that patients receiving long-term treatment with this NSAID should undergo regular medical supervision. Monitoring specifically includes regular assessment of renal (kidney) function to check for adverse events.
